Logo image of NVNO

ENVVENO MEDICAL CORP (NVNO) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:NVNO - US29415J1060 - Common Stock

0.3135 USD
-0.05 (-13.18%)
Last: 1/15/2026, 4:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
NVNO revenue by date.NVNO revenue by date.
420K
-46.84%
190K
-54.76%
30K
-84.21%

-100.00%
7.14M17.136M
140.00%
29.294M
70.95%
EBITDA
YoY % growth
NVNO ebitda by date.NVNO ebitda by date.
-5.97M
-32.37%
-7.4M
-23.95%
-6.97M
5.81%
N/A
-29.70%
N/A
-85.18%
N/A
-47.67%
N/A
-0.24%
N/A
3.91%
N/AN/AN/AN/A
EBIT
YoY % growth
NVNO ebit by date.NVNO ebit by date.
-6.11M
-31.12%
-7.53M
-23.24%
-7.09M
5.84%
-7.181M
-28.91%
-12.842M
-84.79%
-25.724M
-47.60%
-27.234M
-0.28%
-23.735M
4.00%
-24.235M
-0.98%
-24.317M
-0.34%
-19.523M
19.71%
-12.362M
36.68%
Operating Margin
NVNO operating margin by date.NVNO operating margin by date.
-1,454.76%-3,963.16%-23,633.33%N/AN/AN/AN/AN/AN/A-340.57%-113.93%-42.20%
EPS
YoY % growth
NVNO eps by date.NVNO eps by date.
N/AN/AN/A-0.35
97.22%
-1.40
-465.17%
-2.25
-11.73%
-2.11
10.50%
-1.35
35.20%
-1.10
13.26%
-1.02
7.41%
-0.75
26.00%
-0.48
36.49%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.29
4.80%
-0.24
-11.27%
-0.27
19.64%
-0.27
-15.30%
-0.23
17.86%
-0.19
20.83%
-0.20
23.08%
-0.20
23.08%
-0.15
34.78%
Revenue
Q2Q % growth
510K1.02M2.295M3.315M2.856M
460.00%
3.672M
260.00%
4.478M
95.12%
6.13M
84.92%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-6.497M
3.01%
-5.824M
-17.57%
-6.406M
9.13%
-6.446M
-32.02%
-5.641M
13.19%
-5.08M
12.78%
-5.192M
18.95%
-5.294M
17.88%
-3.958M
29.84%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.23
34.29%
-0.310.0824.84%
Q2 2025
Q2Q % growth
-0.33
-6.45%
-0.29-0.04-15.55%
Q1 2025
Q2Q % growth
-0.22
29.03%
-0.350.1336.56%
Q4 2024
Q2Q % growth
-0.30
16.67%
-0.360.0615.97%
Q3 2024
Q2Q % growth
-0.35
22.22%
-0.34-0.01-3.98%
Q2 2024
Q2Q % growth
-0.31
46.55%
-0.370.0615.58%
Q1 2024
Q2Q % growth
-0.31
45.61%
-0.410.1024.02%
Q4 2023
Q2Q % growth
-0.36
34.55%
-0.470.1123.27%
Q3 2023
Q2Q % growth
-0.45
16.67%
-0.490.048.09%
Q2 2023
Q2Q % growth
-0.58
7.94%
-0.50-0.08-16.05%
Q1 2023
Q2Q % growth
-0.57
-21.28%
-0.49-0.08-16.42%
Q4 2022
Q2Q % growth
-0.55
41.49%
-0.580.035.40%
Q3 2022
Q2Q % growth
-0.54
-107.69%
-0.53-0.01-1.81%
Q2 2022
Q2Q % growth
-0.63
-125.00%
-0.34-0.29-87.17%
Q1 2022
Q2Q % growth
-0.47
2.08%
-0.30-0.17-58.89%
Q4 2021
Q2Q % growth
-0.94
61.79%
-0.34-0.60-179.26%
Q3 2021
Q2Q % growth
-0.26
79.20%
-0.350.0925.03%
Q2 2021
Q2Q % growth
-0.28 -0.350.0719.26%
Q1 2021
Q2Q % growth
-0.48 -0.35-0.13-38.41%
Q4 2020
Q2Q % growth
-2.46 -1.00-1.46-146.10%
Q3 2020
Q2Q % growth
-1.25 -1.280.021.96%
NVNO Yearly EPS VS EstimatesNVNO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -2 -4 -6 -8 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
NVNO Yearly Revenue VS EstimatesNVNO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2026 2027 2028 5M 10M 15M 20M 25M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
RevenueN/A N/A N/A N/A